Show simple item record

dc.contributor.authorSingh, Heena ; Yang, An-Dau ; Egan, Cay ; Magliocco, Tonyeng
dc.description.abstractAlthough many improvements in prognostic and therapeutic treatments for Breast Cancer(BC) have been made, metastasis remains the major cause of all BC related deaths. Hormonal estrogen plays a crucial role in the maintenance of bones and BC formation. Its cellular mechanism of action is mediated by the nuclear receptor Estrogen receptor-1 (ERα) where status of primary tumor estrogen responsiveness (positive or negative) is used as a prognostic indicator in the treatment of BC and correlates with ER status of bone metastasis. Patients with ER+ BC develop bone metastasis three times more than patients negative for ER. Previous research shows that stable introduction of ERα in ERα negative BC cells can inhibit their skeletal metastasis in mice models. This project assess whether ERα positive cells migrates preferentially towards bone cells in presence of bone marrow derived cells in vitro.eng
dc.description.sponsorshipO' Brien Centre for the BHSceng
dc.rightsAttribution Non-Commercial No Derivatives 3.0 Unported*
dc.subjectBreast Cancereng
dc.subject.otherEstrogen Receptor Alphaeng
dc.titleMigration of Estrogen Receptor -1 (ER-α) positive breast cancer cells to bone in response to bone cellseng
dc.typeconference poster
dc.publisher.corporateUniversity of Calgaryeng
dc.identifier.doi Scienceseng

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution Non-Commercial No Derivatives 3.0 Unported
Attribution Non-Commercial No Derivatives 3.0 Unported